Insider Transactions in Q3 2025 at Standard Biotools Inc. (LAB)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.16%
|
$100,000
$1.29 P/Share
|
|
Sep 04
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+0.41%
|
$250,000
$1.28 P/Share
|
|
Sep 03
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+0.41%
|
$250,000
$1.27 P/Share
|
|
Aug 26
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
125,000
+0.21%
|
$125,000
$1.26 P/Share
|
|
Aug 25
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+0.33%
|
$200,000
$1.24 P/Share
|
|
Aug 22
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+0.33%
|
$200,000
$1.26 P/Share
|
|
Aug 20
2025
|
Hanjoon Alex Kim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,739
-0.52%
|
$12,739
$1.27 P/Share
|
|
Aug 20
2025
|
Sean Mackay SVP & Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,661
-2.4%
|
$19,661
$1.27 P/Share
|
|
Aug 20
2025
|
Michael Egholm President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
54,919
-0.96%
|
$54,919
$1.27 P/Share
|
|
Aug 15
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
150,000
+0.25%
|
$150,000
$1.22 P/Share
|
|
Aug 14
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
133,220
+0.22%
|
$133,220
$1.21 P/Share
|
|
Aug 13
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
75,000
+0.13%
|
$75,000
$1.31 P/Share
|
|
Aug 01
2025
|
Hanjoon Alex Kim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+38.07%
|
-
|
|
Aug 01
2025
|
Michael Egholm President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,000,000
+34.34%
|
-
|